Status:
TERMINATED
Physio PCI: Impact of Coronary Angioplasty on Non-hyperaemic Pressure Ratio in Patients With Coronary Artery Disease
Lead Sponsor:
Ceric Sàrl
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
21+ years
Brief Summary
The use of intra coronary physiological assessment with fractional flow reserve (FFR) is nowadays the standard approach to define ischemia-inducing stenosis and guide myocardial revascularization stra...
Eligibility Criteria
Inclusion
- Patient is ≥ 21 years
- The patient is deemed eligible for PCI of at least one coronary stenosis (RFRpre ≤0.89 or FFR≤0.80)
- The patient is able and is willing to comply with all study procedures and process.
Exclusion
- The patient is in cardiogenic shock
- The patient has a bifurcation lesion that requires a planned two stents technique
- The patient refuses to participate.
- The patient suffers acute coronary syndrome and should be treated by PCI in the culprit lesion (non-culprit lesions in non-culprit vessel could be included)
- The patient has an ostial stenosis to be treated by PCI
Key Trial Info
Start Date :
June 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04679805
Start Date
June 6 2021
End Date
July 1 2021
Last Update
March 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al Qassimi Hospital
Sharjah city, United Arab Emirates